Curran Terrie insider trades
Curran Terrie has filed 28 Form 4s with the SEC that we hold, for Phathom Pharmaceuticals, Inc. (PHAT) (President and Chief Executive, Director), Arcutis Biotherapeutics, Inc. (ARQT) (Director) and MYOV (Director). Across all of them we count 2 purchases worth $252.9K and 13 sales worth $3.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($984.0K). The largest single trade was a sale of 37,135 shares of MYOV worth $929.5K, dated 2021-09-02. Of 3 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-03 and the latest 2026-08-28.
Phathom Pharmaceuticals, Inc. (PHAT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-05-13 | P, purchase reported on Form 4 | 20,500 | $151.9K | 2022-05-16 | SEC |
| 2022-11-21 | S, sale reported on Form 4 | 1,526 | $14.6K | 2022-11-23 | SEC |
| 2023-01-20 | S, sale reported on Form 4 | 5,821 | $47.7K | 2023-01-20 | SEC |
| 2023-03-01 | S, sale reported on Form 4 | 1,436 | $12.3K | 2023-03-03 | SEC |
| 2023-04-06 | P, purchase reported on Form 4 | 12,919 | $101.0K | 2023-04-07 | SEC |
| 2024-03-22 | S, sale reported on Form 4 | 16,851 | $153.5K | 2024-03-26 | SEC |
| 2024-07-15 | S, sale reported on Form 4 | 33,848 | $396.7K | 2024-07-17 | SEC |
| 2025-01-21 | S, sale reported on Form 4 | 19,109 | $125.9K | 2025-01-23 | SEC |
Arcutis Biotherapeutics, Inc. (ARQT)
MYOV
Counted from the Form 4 filings this reporting owner (SEC CIK 1690298) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
